BOSTON SCIENTIFIC CORP — Director's Dealing 2018

May 8, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2018-05-07

Reporting Person: Ballinger Kevin J. (EVP & Pres, Interven Cardio)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-05-07	Common Stock	M	31056.0000	$7.1600	Acquired	102207.0000	Direct
2018-05-07	Common Stock	S	31056.0000	$30.0000	Disposed	71151.0000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-05-07	Stock Option (Right to Buy)	$7.1600	M	31056.0000	Disposed	2021-02-28	Common Stock (31056.0000)	Direct

Footnotes

F1: This transaction was effected pursuant to a pre-established Rule 10b5-1 trading plan.

F2: Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available.

F3: Grant to the reporting person of an option to purchase 62,112 shares of common stock vesting in four annual increments beginning on February 28, 2012, the first anniversary of the grant.